April 21, 2026
Endothelial senescence Long COVID senolytics explained: how SARS-CoV-2 locks blood vessel cells into a toxic zombie state, drives microclots and brain fog, and what the emerging 4-layer senolytic protocol does about it.
April 17, 2026
The first dedicated RCT of stellate ganglion block for Long COVID POTS launched in 2026. Here's everything that's changed: the STAR-CO trial protocol, the Frontiers in Neuroscience editorial endorsement, new mechanistic data on catecholamine-driven mitochondrial uncoupling, and the updated clinical protocol for autonomic reset.
April 7, 2026
Stellate ganglion block for Long COVID dysautonomia has entered formal NIH clinical validation in 2026. We break down the STAR-CO trial, the cervical sympathetic mechanism, catecholamine-driven mitochondrial uncoupling, and the full SGB stacking protocol for finance professionals.
April 1, 2026
The January 2026 Lancet eClinicalMedicine RCT tested home-based intranasal and transcranial photobiomodulation in Long COVID patients with brain fog. Near-infrared light targets cytochrome c oxidase — the suppressed rate-limiting enzyme of neuronal ATP production — restoring bioenergetic function while dampening microglial neuroinflammation.
March 27, 2026
A landmark 2025 Griffith University study reveals that low dose naltrexone TRPM3 long COVID research has delivered the most mechanistically specific finding yet: LDN restores the faulty ion channel that keeps Long COVID patients bioenergetically stuck.
March 22, 2026
Nattokinase for Long COVID is emerging as one of the most mechanistically coherent post-viral recovery interventions. Backed by the Tanikawa et al. 2022 spike protein degradation study and Pretorius microclot research, this deep-dive explains the bioenergetic failure cascade and presents a stacked protocol for finance professionals.
March 18, 2026
Remedy Place and NADclinic just launched at-home NAD+ injections via a 99 Smart Pen. Here's the science, the company controversy, and what finance professionals should actually know before buying.
March 17, 2026
Mitochondrial health for professionals is now front-page science — and it directly impacts your energy, focus, and career longevity. Learn how chronic stress damages your mitochondria, and what NAD+, NMN, Urolithin A, and lifestyle interventions can do to reverse it.
March 12, 2026
The NCI is officially studying ivermectin for cancer — and the broader science of parasite cancer treatment is accelerating. Here's what the peer-reviewed evidence actually says.
February 27, 2026
GLP-1 for professionals: everything finance and banking executives need to know about Ozempic, tirzepatide, muscle loss, protein needs, gut health effects, and the rebound risk when you stop.
